{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:39:13Z","timestamp":1791041953986,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T00:00:00Z","timestamp":1163635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T00:00:00Z","timestamp":1163635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2007,1,1]]},"DOI":"10.1038\/sj.gene.6364355","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T05:22:32Z","timestamp":1163654552000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Identification of a novel G245R polymorphism in the IL-2 receptor \u03b2 membrane proximal domain associated with human visceral leishmaniasis"],"prefix":"10.1038","volume":"8","author":[{"given":"B","family":"Bucheton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Argiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Chevillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Kheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"El-Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Dessein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,16]]},"reference":[{"key":"BF6364355_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1359-6101(97)00021-X","volume":"8","author":"JX Lin","year":"1997","unstructured":"Lin JX, Leonard WJ . Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev 1997; 8: 313\u2013332.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF6364355_CR2","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.4049\/jimmunol.172.7.3983","volume":"172","author":"BH Nelson","year":"2004","unstructured":"Nelson BH . IL-2, regulatory T cells, and tolerance. J Immunol 2004; 172: 3983\u20133988.","journal-title":"J Immunol"},{"issue":"11 Suppl 13","key":"BF6364355_CR3","first-page":"4","volume":"16","author":"J Dutcher","year":"2002","unstructured":"Dutcher J . Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma. Oncology (Williston Park) 2002; 16 (11 Suppl 13): 4\u201310.","journal-title":"Oncology (Williston Park)"},{"key":"BF6364355_CR4","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1073\/pnas.93.19.10405","volume":"93","author":"EL Jacobson","year":"1996","unstructured":"Jacobson EL, Pilaro F, Smith KA . Rational interleukin-2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proc Natl Acad Sci USA 1996; 93: 10405\u201310410.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6364355_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0952-7915(98)80215-X","volume":"10","author":"TA Waldmann","year":"1998","unstructured":"Waldmann TA, O'Shea J . The use of antibodies against the IL-2 receptor in transplantation. Curr Opin Immunol 1998; 10: 507\u2013512.","journal-title":"Curr Opin Immunol"},{"key":"BF6364355_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1568008053174741","volume":"5","author":"VI Kozanidou","year":"2005","unstructured":"Kozanidou VI, Theocharis AD, Georgiadis A, Voulgari PV, Drosos AA, Karamanos NK . Signal transduction by IL-2 and its receptors as target in treatment of rheumatoid arthritis. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5: 41\u201350.","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"BF6364355_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1006\/cyto.2001.0862","volume":"14","author":"SL Gaffen","year":"2001","unstructured":"Gaffen SL . Signaling domains of the interleukin-2 receptor. Cytokine 2001; 14: 63\u201377.","journal-title":"Cytokine"},{"key":"BF6364355_CR8","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1126\/science.7973658","volume":"266","author":"SM Russell","year":"1994","unstructured":"Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M et al. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 1994; 266: 1042\u20131045.","journal-title":"Science"},{"key":"BF6364355_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.7973659","volume":"266","author":"T Miyazaki","year":"1994","unstructured":"Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994; 266: 1045\u20131047.","journal-title":"Science"},{"key":"BF6364355_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1359-6101(01)00023-5","volume":"13","author":"JM Ellery","year":"2002","unstructured":"Ellery JM, Nicholls PJ . Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev 2002; 13: 27\u201340.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Suppl 2","key":"BF6364355_CR11","doi-asserted-by":"publisher","first-page":"S305","DOI":"10.1086\/513843","volume":"179","author":"RM Locksley","year":"1999","unstructured":"Locksley RM, Pingel S, Lacy D, Wakil AE, Bix M, Fowell DJ . Susceptibility to infectious diseases: Leishmania as a paradigm. J Infect Dis 1999; 179 (Suppl 2): S305\u2013S308.","journal-title":"J Infect Dis"},{"key":"BF6364355_CR12","first-page":"207","volume":"51","author":"M Ho","year":"1983","unstructured":"Ho M, Koech DK, Iha DW, Bryceson AD . Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol 1983; 51: 207\u2013214.","journal-title":"Clin Exp Immunol"},{"key":"BF6364355_CR13","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1172\/JCI112209","volume":"76","author":"EM Carvalho","year":"1985","unstructured":"Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson Jr WD . Absence of gamma interferon and interleukin-2 production during active visceral leishmaniasis. J Clin Invest 1985; 76: 2066\u20132069.","journal-title":"J Clin Invest"},{"key":"BF6364355_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/0020-7519(94)00220-I","volume":"25","author":"Z Eslami","year":"1995","unstructured":"Eslami Z, Olivier M, Tanner CE . Immunotherapy with IL-2-stimulated splenocytes reduces in vitro the level of Leishmania donovani infection in peritoneal macrophages. Int J Parasitol 1995; 25: 975\u2013981.","journal-title":"Int J Parasitol"},{"key":"BF6364355_CR15","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.152.12.5949","volume":"152","author":"EM Carvalho","year":"1994","unstructured":"Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG . Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994; 152: 5949\u20135956.","journal-title":"J Immunol"},{"key":"BF6364355_CR16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4049\/jimmunol.147.1.281","volume":"147","author":"M Barral-Netto","year":"1991","unstructured":"Barral-Netto M, Barral A, Santos SB, Carvalho EM, Badaro R, Rocha H et al. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol 1991; 147: 281\u2013284.","journal-title":"J Immunol"},{"key":"BF6364355_CR17","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1086\/379084","volume":"73","author":"B Bucheton","year":"2003","unstructured":"Bucheton B, Abel L, El-Safi S, Kheir MM, Pavek S, Lemainque A et al. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am J Hum Genet 2003; 73: 1052\u20131060.","journal-title":"Am J Hum Genet"},{"key":"BF6364355_CR18","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S1286-4579(02)00027-8","volume":"4","author":"B Bucheton","year":"2002","unstructured":"Bucheton B, Kheir MM, El-Safi SH, Hammad A, Mergani A, Mary C et al. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 2002; 4: 1449\u20131457.","journal-title":"Microbes Infect"},{"key":"BF6364355_CR19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S1286-4579(02)00026-6","volume":"4","author":"S EL-Safi","year":"2002","unstructured":"EL-Safi S, Bucheton B, Kheir MM, Musa HA, M EL-O, Hammad A et al. Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996\u20131997). Microbes Infect 2002; 4: 1439\u20131447.","journal-title":"Microbes Infect"},{"issue":"Part 1","key":"BF6364355_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/bj3060217","volume":"306","author":"OM Howard","year":"1995","unstructured":"Howard OM, Kirken RA, Garcia GG, Hackett RH, Farrar WL . Structural domains of interleukin-2 receptor beta critical for signal transduction: kinase association and nuclear complex-formation. Biochem J 1995; 306 (Part 1): 217\u2013224.","journal-title":"Biochem J"},{"key":"BF6364355_CR21","doi-asserted-by":"publisher","first-page":"22176","DOI":"10.1074\/jbc.270.38.22176","volume":"270","author":"KD Liu","year":"1995","unstructured":"Liu KD, Lai SY, Goldsmith MA, Greene WC . Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction. J Biol Chem 1995; 270: 22176\u201322181.","journal-title":"J Biol Chem"},{"key":"BF6364355_CR22","doi-asserted-by":"crossref","first-page":"14698","DOI":"10.1016\/S0021-9258(17)36681-4","volume":"269","author":"MA Goldsmith","year":"1994","unstructured":"Goldsmith MA, Xu W, Amaral MC, Kuczek ES, Greene WC . The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elements. J Biol Chem 1994; 269: 14698\u201314704.","journal-title":"J Biol Chem"},{"key":"BF6364355_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1006\/cyto.1995.0081","volume":"7","author":"RA Kirken","year":"1995","unstructured":"Kirken RA, Rui H, Malabarba MG, Howard OM, Kawamura M, O'Shea JJ et al. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. Cytokine 1995; 7: 689\u2013700.","journal-title":"Cytokine"},{"key":"BF6364355_CR24","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.1074\/jbc.273.17.10719","volume":"273","author":"MH Zhu","year":"1998","unstructured":"Zhu MH, Berry JA, Russell SM, Leonard WJ . Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to IL-2Rbeta. J Biol Chem 1998; 273: 10719\u201310725.","journal-title":"J Biol Chem"},{"key":"BF6364355_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev.iy.13.040195.002101","volume":"13","author":"JN Ihle","year":"1995","unstructured":"Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O . Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 1995; 13: 369\u2013398.","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 1","key":"BF6364355_CR26","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1002\/1098-2272(2000)19:1+<::AID-GEPI6>3.0.CO;2-M","volume":"19","author":"NM Laird","year":"2000","unstructured":"Laird NM, Horvath S, Xu X . Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19 (Suppl 1): S36\u2013S42.","journal-title":"Genet Epidemiol"},{"key":"BF6364355_CR27","first-page":"506","volume":"52","author":"RS Spielman","year":"1993","unstructured":"Spielman RS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506\u2013516.","journal-title":"Am J Hum Genet"},{"key":"BF6364355_CR28","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1086\/316895","volume":"67","author":"SL Lake","year":"2000","unstructured":"Lake SL, Blacker D, Laird NM . Family-based tests of association in the presence of linkage. Am J Hum Genet 2000; 67: 1515\u20131525.","journal-title":"Am J Hum Genet"},{"key":"BF6364355_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/intimm\/2.6.481","volume":"2","author":"K Nishikawa","year":"1990","unstructured":"Nishikawa K, Saito S, Morii T, Kato Y, Narita N, Ichijo M et al. Differential expression of the interleukin-2 receptor beta (p75) chain on human peripheral blood natural killer subsets. Int Immunol 1990; 2: 481\u2013486.","journal-title":"Int Immunol"},{"key":"BF6364355_CR30","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1084\/jem.171.5.1821","volume":"171","author":"I Espinoza-Delgado","year":"1990","unstructured":"Espinoza-Delgado I, Ortaldo JR, Winkler-Pickett R, Sugamura K, Varesio L, Longo DL . Expression and role of p75 interleukin-2 receptor on human monocytes. J Exp Med 1990; 171: 1821\u20131826.","journal-title":"J Exp Med"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/6364355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6364355","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6364355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T09:00:52Z","timestamp":1707382852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6364355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1,1]]}},"alternative-id":["BF6364355"],"URL":"https:\/\/doi.org\/10.1038\/sj.gene.6364355","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,16]]},"assertion":[{"value":"15 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}